Company Profile
Evogene is a computational biology company in Israel, the United States, Europe, and Africa. Its business is organized into three segments: Agriculture, Human Health, and Industrial Applications.
The company engages in the agricultural activities, including seed traits and ag-chemicals activities design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. Additionally, it medical cannabis products.
It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity including inflammatory bowel disease (IBD). Incorporated in 1999, the company is headquartered in Rehovot, Israel.